Biotech & AI drug discoveryNature Medicine

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

This item is the headline of a randomized placebo-controlled trial, published by Nature Medicine, examining the effects of semaglutide on kidney disease in type 2 diabetes. No results or additional context are provided in the feed, so no outcome can be stated.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-01T00:00:00+00:00

Published here2026-10-01T11:07:04+00:00

Original source

Nature Medicine

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41591-026-04674-2

Original headline

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.